In a major step toward implementing the "Most-Favored-Nation" (MFN) pricing policy, the Trump administration has announced individual agreements with nine... Read more
Category: Uncategorized
AstraZeneca Inks $2 Billion Deal to Secure Next-Generation Cancer Inhibition Technology
AstraZeneca has officially entered into a global licensing agreement worth up to $2 billion for Jacobio Pharma’s Pan-KRAS inhibitor candidate,... Read more
Korean Bio-Pharma Giant Establishes First Manufacturing Foothold in the United States
Samsung Biologics has secured a $280 million deal to acquire GSK’s manufacturing facilities located in Rockville, Maryland. This strategic move... Read more
Rare Disease Market Shifts as Shionogi Inks $2.5 Billion Asset Acquisition
On December 22, Shionogi revealed a definitive agreement to acquire the amyotrophic lateral sclerosis (ALS) portfolio from Tanabe Pharma. The... Read more
Obesity Treatment Frontier: FDA Approves First-Ever Oral GLP-1 Tablet
The global healthcare market has reached a historic milestone with the FDA's official approval of the oral tablet formulation of... Read more
Unauthorized Clinic in Hue Shutdown Following Severe Regulatory Violations
On December 22, the Hue City Department of Health announced an administrative penalty against the Mb Center (located on To... Read more
Central Vietnam Pharmaceutical Company Sanctioned for Quality Standard Violations
The Drug Administration of Vietnam, under the Ministry of Health, has issued an administrative sanction against Medipharco Pharmaceutical Joint Stock... Read more
Ho Chi Minh City Medical Sector Launches Online Public Feedback Monitoring Mechanism
During an online briefing on December 22, the Ho Chi Minh City Department of Health officially introduced a specialized technical... Read more
Hữu Nghị Hospital Enhances Medical Response Capacity with New Specialized Transport
On December 22, a medical equipment handover ceremony took place as Hữu Nghị Hospital received a new specialized ambulance. This... Read more









